DiscoverThe Chain: Protein Engineering PodcastEpisode: 54 - Enkelejda Miho on the Current State of AI: Drug Development, Research, and the Future
Episode: 54 - Enkelejda Miho on the Current State of AI: Drug Development, Research, and the Future

Episode: 54 - Enkelejda Miho on the Current State of AI: Drug Development, Research, and the Future

Update: 2023-10-17
Share

Description

With the whirlwind development of AI, it can be difficult to keep track of its uses in both research and the market. In this episode of The Chain podcast, host Ben Hackel, Professor of Chemical Engineering & Materials Science at the University of Minnesota, speaks with Enkelejda “Ledi” Miho, Professor of Digital Life Sciences at the University of Applied Sciences Northwestern Switzerland FHNW, who breaks down the current state of AI and its role in drug development. She talks about the opportunities of AI and drug discovery and how digital biomarkers and molecular data are helping with personalized medicine. Miho also discusses the challenges of advancing AI, why having an “adisciplinary” approach is the key to assembling the right team, and how to design studies to be as broadly robust as possible, as well as the advancements of her and her team’s own research. 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode: 54 - Enkelejda Miho on the Current State of AI: Drug Development, Research, and the Future

Episode: 54 - Enkelejda Miho on the Current State of AI: Drug Development, Research, and the Future

Cambridge Healthtech Institute